Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
The European Respiratory Journal
|
December 5, 1997
c-ANCA positivity in a Belgian patient with pulmonary paracoccidioidomycosis
I Stappaerts, J Bogers, D Ebo, et al.
The European Respiratory Journal
|
January 1, 1991
Disseminated lung cancer or extragonadal germ cell tumour?
E Wouters, J Van Meerbeeck, L Dirix, et al.
Virchows Archiv : an International Journal of Pathology
|
January 1, 1994
Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
K Segers, M Ramael, S K Singh, et al.
The Journal of Pathology
|
May 1, 1992
Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1
M Ramael, J van den Bossche, C Buysse, et al.
The European Respiratory Journal
|
October 1, 1996
Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries
C Janson, W De Backer, T Gislason, et al.
Journal of Internal Medicine
|
March 1, 1995
Daytime sleepiness, snoring and gastro-oesophageal reflux amongst young adults in three European countries
C Janson, T Gislason, W De Backer, et al.
Sleep
|
September 1, 1995
Prevalence of sleep disturbances among young adults in three European countries
C Janson, T Gislason, W De Backer, et al.
The European Respiratory Journal
|
March 1, 1991
Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease
P A Bardsley, P Howard, W DeBacker, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 1, 1996
Evaluation and prognostic value of DNA content and of morphometric parameters in malignant mesothelioma using digital image analysis
K Segers, S K Singh, A Van Daele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
A phase II trial of dose-escalated doxorubicin and ifosfamide/mesna in patients with malignant mesothelioma
L Y Dirix, J van Meerbeeck, D Schrijvers, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
The European Respiratory Journal
|
December 5, 1997
c-ANCA positivity in a Belgian patient with pulmonary paracoccidioidomycosis
I Stappaerts, J Bogers, D Ebo, et al.
The European Respiratory Journal
|
January 1, 1991
Disseminated lung cancer or extragonadal germ cell tumour?
E Wouters, J Van Meerbeeck, L Dirix, et al.
Virchows Archiv : an International Journal of Pathology
|
January 1, 1994
Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
K Segers, M Ramael, S K Singh, et al.
The Journal of Pathology
|
May 1, 1992
Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1
M Ramael, J van den Bossche, C Buysse, et al.
The European Respiratory Journal
|
October 1, 1996
Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries
C Janson, W De Backer, T Gislason, et al.
Journal of Internal Medicine
|
March 1, 1995
Daytime sleepiness, snoring and gastro-oesophageal reflux amongst young adults in three European countries
C Janson, T Gislason, W De Backer, et al.
Sleep
|
September 1, 1995
Prevalence of sleep disturbances among young adults in three European countries
C Janson, T Gislason, W De Backer, et al.
The European Respiratory Journal
|
March 1, 1991
Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease
P A Bardsley, P Howard, W DeBacker, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 1, 1996
Evaluation and prognostic value of DNA content and of morphometric parameters in malignant mesothelioma using digital image analysis
K Segers, S K Singh, A Van Daele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 1, 1994
A phase II trial of dose-escalated doxorubicin and ifosfamide/mesna in patients with malignant mesothelioma
L Y Dirix, J van Meerbeeck, D Schrijvers, et al.
Page
of 8